NasdaqGS:CLOVHealthcare
Clover Health (CLOV) Stock Reprices As Profitability Finally Starts To Stick
Clover Health stock rose 12.7% to about US$4.67 into the close, and the mood shift is all about profitability finally showing up in the numbers. The company reported Q2 net income of US$28 million on revenue of US$743 million, its second straight profitable quarter, which is notable for a Medicare Advantage insurer that has spent years in the red.
The market appears focused on that earnings shift and the raised 2026 guidance for revenue and adjusted EBITDA. The key question for investors now...